LATE TREATMENT EFFECTS AND CANCER SURVIVOR CARE IN THE YOUNG. FROM CHILDHOOD TO EARLY ADULTHOOD

Chapter 1. Cardiotoxicity after Childhood Cancer Treatment
Chapter 2. Kidney
Chapter 3. Ototoxicity after Childhood Cancer Treatment
Chapter 4. Complications in tumour orthopaedics
Chapter 5. Causes and course of (severe) late effects – GI tract
Chapter 6. Pulmonary toxicity - Causes and course of (severe) late effects in the Lungs
Chapter 7. Growth hormone deficiency in adult childhood cancer survivors
Chapter 8. Endocrine Late Effects – Thyroid Gland
Chapter 9. Disorders of gonadal and reproductive function in survivors of childhood cancer
Chapter 10. Fertility protection in childhood, adolescents and young adulthood cancer patients
Chapter 11. Endocrine Late Effects - Adrenal Gland
Chapter 12. Pregnancy and Birth
Chapter 13. Endocrine Late Effects - Obesity and Metabolic Syndrome after Childhood Cancer
Chapter 14. Subsequent primary cancer after childhood,teenage and young adult cancer
Chapter 15. Diagnostic of Late Treatment effects: Neuropsychological Short Assessment of Disease- and Treatment-related Intelligence Deficits in Children with Brain Tumors
Chapter 16. Long-term Positive and Negative Psychosocial Outcomes in Young Childhood Cancer Survivors and their Healthy Peers – Posttraumatic Stress Disorder / Somatoform Disorder
Chapter 17. Cancer related fatigue
Chapter 18. Late effects after treatment of acute lymphoblastic leukemia in childhood and adolescence
Chapter 19. Late effects after treatment of acute myeloic leukemia
Chapter 20. Side Effects and Sequelae of Treatment for Chronic Myeloid Leukemia in Childhood and Adolescence
Chapter 21. Late e?ects after treatment of Non-Hodgkin lymphoma in childhood and adolescents
Chapter 22. Late e?ects after treatment of Hodgkin lymphoma
Chapter 23. Langerhans Cell Histiocytosis
Chapter 24. Diagnostics and Diagnosis of Late Effectsin Childhood Brain Tumour Survivors
Chapter 25. Late effects in children and adolescents with neuroblastoma
Chapter 26. Late effects in children and adolescents with nephroblastoma
Chapter 27. Hepatoblastoma and Hepatocellular Carcinoma
Chapter 28. Long Term Sequelae after retinoblastoma
Chapter 29. Late effects in children and adolescents with Ewing Sarcoma
Chapter 30. Late effects in children and adolescents with osteosarcoma
Chapter 31. Late effects in children and adolescents with soft tissue sarcoma
Chapter 32. Potential late effects of rhabdoid tumor therapy
Chapter 33. Late effects after treatment of malignant endocrine tumors
Chapter 34. Skin cancer – treatment and implications for the long term follow up
Chapter 35. Breast Cancer
Chapter 36. Colorectal carcinoma
Chapter 37. Genetic predisposition to late effects - pharmacogenomics of cisplatin-induced ototoxicity
Chapter 38. Physical activity, exercise, and sports
Chapter 39. Late effects after radiotherapy
Chapter 40. Long-Term Follow-Up from the Point of View of a Person A?ected
Chapter 41. Networks of Survivorship Care.

This comprehensive guide describes the aftercare that is appropriate in young cancer patients and discusses in detail the risk and detection of treatment sequelae. It explains the impacts on body and mind of both the disease itself and the different risk-adapted cancer treatments currently in use. Clear guidance is provided on diagnosis and management of the principal treatment-related toxicities in different organs and organ systems and for a wide variety of tumor types. In addition, the role of genetic polymorphisms in the development of adverse therapy-related outcomes is explored, and advice offered on genetic counselling. As the number of long-term survivors of childhood cancer and of cancer in young adults continues to grow, so issues surrounding potential sequelae, second malignancies, and quality of life are becoming ever more important. All practitioners involved in the care of young cancer patients will find this book to be a helpful source of up-to-date information and assistance.

Features
• Offers clear guidance on cancer aftercare and the diagnosis and management of treatment-related toxicities in the young Covers the full range of organs, organ systems, settings, and tumor types
• Explores the role of genetic polymorphisms in adverse therapy-related outcomes